Omentin inhibits TNF-α-induced expression of adhesion molecules in endothelial cells via ERK/NF-κB pathway

Biochemical and Biophysical Research Communications

Volumn 425, Issue 2, 2012, Pages 401-406

  Zhong, Xia ^a   Li, Xiaonan ^a   Liu, Fuli ^a   Tan, Hui ^a   Shang, Deya ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

ERK; ICAM 1; NF B; Omentin; VCAM 1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; ADIPOCYTOKINE; CELL ADHESION MOLECULE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE; OMENTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

CELLS, CULTURED; CYTOKINES; GPI-LINKED PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LECTINS; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84865379494     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.07.110     Document Type: Article

References (30)

1. Zhang H., Cui J., Zhang C. Emerging role of adipokines as mediators in atherosclerosis. World J. Cardiol. 2010, 2(11):370-376.
2. Galic S., Oakhill J.S., Steinberg G.R. Adipose tissue as an endocrine organ. Mol. Cell Endocrinol. 2010, 316(2):129-139.
3. Rabe K., Lehrke M., Parhofer K.G., Broedl U.C. Adipokines and insulin resistance. Mol. Med. 2008, 14(11-12):741-751.
4. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011, 11(2):85-97.
5. Xiao X., Dong Y., Zhong J., Cao R., Zhao X., Wen G., Liu J. Adiponectin protects endothelial cells from the damages induced by the intermittent high level of glucose. Endocrine 2011, 40(3):386-393.
6. de Souza Batista C.M., Yang R.Z., Lee M.J., Glynn N.M., Yu D.Z., Pray J., Ndubuizu K., Patil S., Schwartz A., Kligman M., Fried S.K., Gong D.W., Shuldiner A.R., Pollin T.I., McLenithan J.C. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007, 56(6):1655-1661.
7. Pan H.Y., Guo L., Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res. Clin. Pract. 2010, 88(1):29-33.
8. Schäffler A., Zeitoun M., Wobser H., Buechler C., Aslanidis C., Herfarth H. Frequency and significance of the novel single nucleotide missense polymorphism Val109Asp in the human gene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseases. Cardiovasc. Diabetol. 2007, 6:3.
9. Senolt L., Polanská M., Filková M., Cerezo L.A., Pavelka K., Gay S., et al. Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Ann. Rheum. Dis. 2010, 69(7):1410-1411.
10. Zhong X., Zhang H.Y., Tan H., Zhou Y., Liu F.L., Chen F.Q., Shang D.Y. Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol. Sin. 2011, 32(7):873-878.
11. Kwak J.H., Jung J.K., Lee H. Nuclear factor-kappa B inhibitors; a patent review (2006-2010). Expert Opin. Ther. Pat. 2011, 21(12):1897-1910.
12. Pahl H.L. Activatorsand targe tgenesof Rel/NF-κB transcription factors. Oncogene 1999, 18(49):6853-6866.
13. Baker R.G., Hayden M.S., Ghosh S. NF-κB, inflammation, and metabolic disease. Cell Metab. 2011 Jan, 13(1):11-22.
14. Zoico E., Garbin U., Olioso D., Mazzali G., Fratta Pasini A.M., Di Francesco V., Sepe A., Cominacini L., Zamboni M. The effects of adiponectin on interleukin-6 and MCP-1 secretion in lipopolysaccharide-treated 3T3-L1 adipocytes: role of the NF-kappaB pathway. Int. J. Mol. Med. 2009, 24(6):847-851.
15. Kim S.R., Bae Y.H., Bae S.K., Choi K.S., Yoon K.H., Koo T.H., Jang H.O., Yun I., Kim K.W., Kwon Y.G., Yoo M.A., Bae M.K. Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells. Biochim. Biophys. Acta 2008, 1783(5):886-895.
16. Lee W.J., Wu C.S., Lin H., Lee I.T., Wu C.M., Tseng J.J., Chou M.M., Sheu W.H. Visfatin-induced expression of inflammatory mediators in human endothelial cells through the NF-kappaB pathway. Int. J. Obes. (Lond.) 2009, 33(4):465-472.
17. Rahman I., Gilmour P.S., Jimenez L.A., MacNee W. Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. Mol. Cell Biochem. 2002, 234-235(1-2):239-248.
18. Meigs J.B., Hu F.B., Rifai N., Manson J.E. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004, 291(16):1978-1986.
19. Ziccardi P., Nappo F., Giugliano G., Esposito K., Marfella R., Cioffi M., D'Andrea F., Molinari A.M., Giugliano D. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002, 105(7):804-809.
20. Lu H.H., Sheng Z.Q., Wang Y., Zhang L. Levels of soluble adhesion molecules in patients with various clinical presentations of coronary atherosclerosis. Chin. Med. J. (Engl.) 2010, 123(21):3123-3126.
21. Kougias P., Chai H., Lin P.H., Yao Q., Lumsden A.B., Chen C. Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J. Surg. Res. 2005, 126(1):121-129.
22. Hsu W.Y., Chao Y.W., Tsai Y.L., Lien C.C., Chang C.F., Deng M.C., Ho L.T., Kwok C.F., Juan C.C. Resistin induces monocyte-endothelial cell adhesion by increasing ICAM-1 and VCAM-1 expression in endothelial cells via p38MAPK-dependent pathway. J. Cell Physiol. 2011, 226(8):2181-2188.
23. Bessa S.S., Hamdy S.M., El-Sheikh R.G. Serum visfatin as a non-traditional biomarker of endothelial dysfunction in chronic kidney disease: an Egyptian study. Eur. J. Int. Med. 2010, 21(6):530-535.
24. Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb. Perspect. Biol. 2009, 1(6):a001651.
25. Lin F.Y., Chen Y.H., Tasi J.S., Chen J.W., Yang T.L., Wang H.J., Li C.Y., Chen Y.L., Lin S.J. Endotoxin induces toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways. Arterioscler. Thromb. Vasc. Biol. 2006, 26(12):2630-2637.
26. Liu R., Wang X., Bu P. Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome. Diabetes Res. Clin. Pract. 2011, 93(1):21-25.
27. Shibata R., Takahashi R., Kataoka Y., Ohashi K., Ikeda N., Kihara S., Murohara T., Ouchi N. Association of a fat-derived plasma protein omentin with carotid artery intima-media thickness in apparently healthy men. Hypertens Res. 2011, 34(12):1309-1312.
28. Yamawaki H., Kuramoto J., Kameshima S., Usui T., Okada M., Hara Y. Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem. Biophys. Res. Commun. 2011, 408(2):339-343.
29. O'Brien K.D., Allen M.D., McDonald T.O., Chait A., Harlan J.M., et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J. Clin. Invest. 1993, 92(2):945-951.
30. O'Brien K.D., McDonald T.O., Chait A., Allen M.D., Alpers C.E. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimalleukocyte content. Circulation 1996, 93(4):672-682.